Bausch Health Companies Inc.
BHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.70 | -0.03 | 0.13 | -0.16 |
| FCF Yield | 42.48% | 25.93% | -43.81% | 11.53% |
| EV / EBITDA | 7.54 | 8.45 | 7.81 | 9.81 |
| Quality | ||||
| ROIC | -2.96% | 6.42% | 3.36% | 1.72% |
| Gross Margin | 71.10% | 70.78% | 70.90% | 71.61% |
| Cash Conversion Ratio | -22.18 | -1.69 | 3.43 | -1.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.81% | 1.26% | 0.40% | -0.65% |
| Free Cash Flow Growth | 65.79% | 176.31% | -187.14% | 42.52% |
| Safety | ||||
| Net Debt / EBITDA | 6.59 | 7.43 | 7.02 | 6.77 |
| Interest Coverage | 1.11 | 0.73 | 0.31 | 0.32 |
| Efficiency | ||||
| Inventory Turnover | 1.74 | 1.66 | 2.17 | 2.41 |
| Cash Conversion Cycle | 204.35 | 200.95 | 168.28 | 166.16 |